Michael Burry
BMY icon

Michael Burry’s Bristol-Myers Squibb BMY Stock Holding History

Michael Burry’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-300,000
Closed -$21.9M – 4
2022
Q1 		$21.9M Hold
300,000
– – 10.88% 2
2021
Q4 		$18.7M Buy
+300,000
New +$17.6M 25.12% 1

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Michael Burry's BMY Position: Q2 2022 in Review

Michael Burry sold out of Bristol-Myers Squibb (BMY) in Q2 2022, closing a stake of 300,000 shares — an estimated $21.9M sold.

Michael Burry first reported a position in BMY in Q4 2021 and held it in 2 quarters. The position peaked at $21.9M in Q1 2022. 2,541 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

  • Michael Burry reported no remaining Bristol-Myers Squibb position as of Q2 2022 after selling out during the quarter.
  • Michael Burry sold 300,000 Bristol-Myers Squibb shares in Q2 2022, an estimated $21.9M.
  • Michael Burry first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 2 quarters.
  • Michael Burry's Bristol-Myers Squibb position peaked at $21.9M in Q1 2022.
  • 2,541 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on Scion Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.